<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. NADLER:H.R. 2375.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8 of the United States Constitution[Page H3303]</pre>]]></constitutionalAuthorityStatementText>
    <relatedBills>
      <item>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-03-25</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <number>1344</number>
        <latestTitle>Competitive DRUGS Act of 2019</latestTitle>
        <congress>116</congress>
      </item>
      <item>
        <type>S</type>
        <latestAction>
          <actionDate>2019-01-09</actionDate>
          <text>Read twice and referred to the Committee on the Judiciary.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
        <number>64</number>
        <latestTitle>Preserve Access to Affordable Generics and Biosimilars Act</latestTitle>
        <congress>116</congress>
      </item>
    </relatedBills>
    <actions>
      <actionByCounts>
        <houseOfRepresentatives>6</houseOfRepresentatives>
      </actionByCounts>
      <item>
        <actionDate>2019-04-30</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Ordered to be Reported by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-30</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2019-04-29</actionDate>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <links />
        <text>Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2019-04-29</actionDate>
        <committee>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
        </committee>
        <links />
        <text>Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2019-04-29</actionDate>
        <committee />
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <text>Introduced in House</text>
      </item>
      <item>
        <actionDate>2019-04-29</actionDate>
        <committee />
        <links />
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <text>Introduced in House</text>
      </item>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <actionStageOverride>1</actionStageOverride>
        <billReferrals>2</billReferrals>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
      </actionTypeCounts>
    </actions>
    <version>1.0.0</version>
    <amendments />
    <committeeReports />
    <congress>116</congress>
    <originChamber>House</originChamber>
    <sponsors>
      <item>
        <middleName />
        <state>NY</state>
        <party>D</party>
        <bioguideId>N000002</bioguideId>
        <firstName>JERROLD</firstName>
        <identifiers>
          <bioguideId>N000002</bioguideId>
          <lisID>850</lisID>
          <gpoId>8069</gpoId>
        </identifiers>
        <fullName>Rep. Nadler, Jerrold [D-NY-10]</fullName>
        <byRequestType />
        <lastName>NADLER</lastName>
        <district>10</district>
      </item>
    </sponsors>
    <title>Preserve Access to Affordable Generics and Biosimilars Act</title>
    <laws />
    <notes />
    <committees>
      <billCommittees>
        <item>
          <chamber>House</chamber>
          <systemCode>hsju00</systemCode>
          <name>Judiciary Committee</name>
          <activities>
            <item>
              <name>Markup by</name>
              <date>2019-04-30T20:46:17Z</date>
            </item>
            <item>
              <name>Referred to</name>
              <date>2019-04-29T18:00:17Z</date>
            </item>
          </activities>
          <type>Standing</type>
          <subcommittees />
        </item>
        <item>
          <chamber>House</chamber>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2019-04-29T18:00:22Z</date>
            </item>
          </activities>
          <type>Standing</type>
          <subcommittees />
        </item>
      </billCommittees>
    </committees>
    <billNumber>2375</billNumber>
    <recordedVotes />
    <updateDate>2019-07-30T13:31:52Z</updateDate>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Competition and antitrust</name>
          </item>
          <item>
            <name>Congressional oversight</name>
          </item>
          <item>
            <name>Contracts and agency</name>
          </item>
          <item>
            <name>Federal Trade Commission (FTC)</name>
          </item>
          <item>
            <name>Intellectual property</name>
          </item>
          <item>
            <name>Judicial review and appeals</name>
          </item>
          <item>
            <name>Licensing and registrations</name>
          </item>
          <item>
            <name>Marketing and advertising</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <billType>HR</billType>
    <cboCostEstimates>
      <item>
        <title>H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act</title>
        <pubDate>2019-05-09T15:29:00Z</pubDate>
        <url>https://www.cbo.gov/publication/55225</url>
      </item>
    </cboCostEstimates>
    <latestAction>
      <actionDate>2019-04-30</actionDate>
      <links />
      <text>Ordered to be Reported by Voice Vote.</text>
    </latestAction>
    <introducedDate>2019-04-29</introducedDate>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116hr2375ih/xml/BILLS-116hr2375ih.xml</url>
          </item>
        </formats>
        <date>2019-04-29T04:00:00Z</date>
      </item>
    </textVersions>
    <createDate>2019-04-30T07:12:10Z</createDate>
    <cosponsors>
      <item>
        <party>R</party>
        <bioguideId>C001093</bioguideId>
        <lastName>Collins</lastName>
        <middleName />
        <fullName>Rep. Collins, Doug [R-GA-9]</fullName>
        <district>9</district>
        <sponsorshipDate>2019-04-29</sponsorshipDate>
        <state>GA</state>
        <sponsorshipWithdrawnDate />
        <identifiers>
          <bioguideId>C001093</bioguideId>
          <lisID>2121</lisID>
          <gpoId />
        </identifiers>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>Doug</firstName>
      </item>
      <item>
        <party>D</party>
        <bioguideId>C001084</bioguideId>
        <lastName>Cicilline</lastName>
        <middleName>N.</middleName>
        <fullName>Rep. Cicilline, David N. [D-RI-1]</fullName>
        <district>1</district>
        <sponsorshipDate>2019-04-29</sponsorshipDate>
        <state>RI</state>
        <sponsorshipWithdrawnDate />
        <identifiers>
          <lisID>2055</lisID>
          <bioguideId>C001084</bioguideId>
          <gpoId>8139</gpoId>
        </identifiers>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <firstName>David</firstName>
      </item>
      <item>
        <party>D</party>
        <bioguideId>C001068</bioguideId>
        <lastName>Cohen</lastName>
        <middleName />
        <fullName>Rep. Cohen, Steve [D-TN-9]</fullName>
        <district>9</district>
        <sponsorshipDate>2019-04-30</sponsorshipDate>
        <state>TN</state>
        <sponsorshipWithdrawnDate />
        <identifiers>
          <gpoId>8156</gpoId>
          <lisID>1878</lisID>
          <bioguideId>C001068</bioguideId>
        </identifiers>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Steve</firstName>
      </item>
      <item>
        <party>R</party>
        <bioguideId>M001187</bioguideId>
        <lastName>Meadows</lastName>
        <middleName />
        <fullName>Rep. Meadows, Mark [R-NC-11]</fullName>
        <district>11</district>
        <sponsorshipDate>2019-05-07</sponsorshipDate>
        <state>NC</state>
        <sponsorshipWithdrawnDate />
        <identifiers>
          <lisID>2142</lisID>
          <bioguideId>M001187</bioguideId>
          <gpoId />
        </identifiers>
        <isOriginalCosponsor>False</isOriginalCosponsor>
        <firstName>Mark</firstName>
      </item>
    </cosponsors>
    <titles>
      <item>
        <title>To prohibit prescription drug companies from compensating other prescription drug companies to delay the entry of a generic drug, biosimilar biological product, or interchangeable biological product into the market.</title>
        <chamberCode />
        <titleType>Official Title as Introduced</titleType>
        <chamberName />
        <parentTitleType />
      </item>
      <item>
        <title>Preserve Access to Affordable Generics and Biosimilars Act</title>
        <chamberCode />
        <titleType>Short Titles as Introduced</titleType>
        <chamberName />
        <parentTitleType />
      </item>
      <item>
        <title>Preserve Access to Affordable Generics and Biosimilars Act</title>
        <chamberCode />
        <titleType>Display Title</titleType>
        <chamberName />
        <parentTitleType />
      </item>
      <item>
        <title>Preserve Access to Affordable Generics and Biosimilars Act</title>
        <chamberCode />
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <chamberName />
        <parentTitleType />
      </item>
    </titles>
    <summaries>
      <billSummaries />
    </summaries>
    <calendarNumbers />
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

